Sum Up The Parts: MTUM Could Be Worth $196 Thursday, April 14, 8:16 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Implied SPXT Analyst Target Price: $88 Monday, May 16, 7:23 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Sum Up The Pieces: VONV Could Be Worth $82 Thursday, June 16, 7:42 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Bullish Two Hundred Day Moving Average Cross - CRL
By Market News Video Staff, Friday, November 11, 11:34 AM ET
In trading on Friday, shares of Charles River Laboratories International Inc. (NYSE:CRL) crossed above their 200 day moving average of $242.11, changing hands as high as $248.17 per share. Charles River Laboratories International Inc. shares are currently trading up about 2.7% on the day. The chart below shows the one year performance of CRL shares, versus its 200 day moving average:
Looking at the chart above, CRL's low point in its 52 week range is $181.36 per share, with $397.77 as the 52 week high point — that compares with a last trade of $245.05. The CRL DMA information above was sourced from TechnicalAnalysisChannel.com
This Article's Word Cloud:AboveAverageCharlesCrossingDividendsFreeFridayInternationalLaboratoriesLookingMovingNYSEReportRiverStartStocksTechnicalAnalysisChannelTheiraboutaboveaveragebelowchangingchartcomparescrossedcurrentlyfromhandshighinformationlastmdashmonthlymovingpaidperformancepointrangeraquosharesharesshowsslideshowsourcedthattheirtradingweekwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.